Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Consensus Recommendation of “Buy” from Brokerages

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) has earned a consensus rating of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, one has issued a buy rating and four have given a strong buy rating to the company.

Several equities research analysts have recently weighed in on RBGLY shares. HSBC raised Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Sanford C. Bernstein downgraded Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a report on Monday, November 4th. Barclays upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Friday, October 4th. Citigroup upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Tuesday, October 1st. Finally, Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, December 11th.

Reckitt Benckiser Group Trading Up 0.3 %

OTCMKTS RBGLY opened at $13.00 on Friday. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a 12 month low of $10.24 and a 12 month high of $15.03. The company’s 50 day simple moving average is $12.19 and its 200 day simple moving average is $11.95.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.